Attending this year’s Association of British Pharmaceutical Industry (ABPI) Conference in London on Thursday 27th April, it quickly became clear that the day would be a notable one – not ju
Boehringer Ingelheim says it may have found the first therapy for diabetic macular ischaemia (DMI), a common and irreversible complication of the eye in people with diabet
It’s 2024, and in most clinical trials, data is still being moved from the EHR to the EDC manually – with employees reading data from one screen and typing it onto another.
